STOCK TITAN

[Form 4] Oscar Health, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Oscar Health insider reporting: Adam McAnaney, the companys Chief Legal Officer, disposed of 1,845 shares of Class A common stock on 09/02/2025 at a reported price of $16.66 per share. After the transaction, he beneficially owns 181,093 shares, which includes shares to be issued upon vesting of restricted stock units (RSUs). The filing states the 1,845 shares were withheld by the issuer to satisfy tax withholding obligations related to RSU vesting rather than an open-market sale.

Segnalazione interna di Oscar Health: Adam McAnaney, Chief Legal Officer della società, ha ceduto 1.845 azioni ordinarie di Classe A il 02/09/2025 al prezzo riportato di $16,66 per azione. Dopo la transazione possiede beneficiariamente 181.093 azioni, compresi i titoli che verranno emessi al momento del vesting delle restricted stock units (RSU). La comunicazione precisa che le 1.845 azioni sono state trattenute dall'emittente per soddisfare gli obblighi di ritenuta fiscale legati al vesting delle RSU e non corrispondono a una vendita sul mercato aperto.

Informe interno de Oscar Health: Adam McAnaney, el Chief Legal Officer de la compañía, dispuso de 1.845 acciones ordinarias Clase A el 02/09/2025 a un precio informado de $16,66 por acción. Tras la operación, posee de forma beneficiaria 181.093 acciones, incluidas las que se emitirán al consolidarse las unidades de acciones restringidas (RSU). La presentación indica que las 1.845 acciones fueron retenidas por el emisor para satisfacer obligaciones de retención fiscal relacionadas con el vesting de las RSU y no se vendieron en el mercado abierto.

Oscar Health 내부 보고: 회사의 최고법무책임자(Chief Legal Officer)인 Adam McAnaney는 2025년 9월 2일에 Class A 보통주 1,845주를 주당 $16.66의 신고가로 처분했습니다. 거래 후 그는 제약주식단위(RSU)의 베스팅 시 발행될 주식을 포함해 실질적으로 181,093주를 보유하고 있습니다. 서류에는 해당 1,845주가 공개 시장에서의 매도가 아니라 RSU 베스팅과 관련된 세금 원천징수 의무를 충족하기 위해 발행자가 주식을 원천징수한 것이라고 명시되어 있습니다.

Information interne d'Oscar Health : Adam McAnaney, directeur juridique de la société, a cédé 1 845 actions ordinaires de catégorie A le 02/09/2025 à un prix déclaré de 16,66 $ par action. Après la transaction, il détient de manière bénéficiaire 181 093 actions, y compris celles qui seront émises lors du vesting des restricted stock units (RSU). le dépôt indique que les 1 845 actions ont été retenues par l'émetteur pour satisfaire les obligations de retenue fiscale liées au vesting des RSU et ne résultent pas d'une vente sur le marché ouvert.

Insider-Meldung von Oscar Health: Adam McAnaney, Chief Legal Officer des Unternehmens, veräußerte am 02.09.2025 1.845 Aktien der Klasse A zu einem gemeldeten Preis von $16,66 je Aktie. Nach der Transaktion besitzt er wirtschaftlich 181.093 Aktien, einschließlich der Aktien, die bei Vesting von Restricted Stock Units (RSUs) ausgegeben werden. Die Meldung gibt an, dass die 1.845 Aktien vom Emittenten einbehalten wurden, um Steuerabzugsverpflichtungen im Zusammenhang mit dem Vesting der RSUs zu erfüllen, und nicht durch einen Verkauf am offenen Markt erzielt wurden.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine tax-withholding disposition; not a discretionary sale and appears immaterial to ownership stake.

The reported disposition is coded as a withholding to cover taxes on vested RSUs, indicating this was an administrative transaction rather than an intentional liquidity event. The amount disposed (1,845 shares) is small relative to the post-transaction beneficial ownership (181,093 shares), so the filing is unlikely to meaningfully change control or signal a shift in insider sentiment. Investors typically treat withholding transactions differently from open-market sales because they do not reflect a decision to monetize shares.

TL;DR: Disclosure is appropriate and follows Section 16 reporting; no governance red flags evident.

The form identifies the reporting person and relationship to the issuer, and explains the nature of the disposal as tax withholding for RSU vesting. The use of the correct transaction code and the explicit explanation reduce ambiguity for stakeholders. There are no indications of unusual timing, large-scale insider selling, or related-party issues in this report.

Segnalazione interna di Oscar Health: Adam McAnaney, Chief Legal Officer della società, ha ceduto 1.845 azioni ordinarie di Classe A il 02/09/2025 al prezzo riportato di $16,66 per azione. Dopo la transazione possiede beneficiariamente 181.093 azioni, compresi i titoli che verranno emessi al momento del vesting delle restricted stock units (RSU). La comunicazione precisa che le 1.845 azioni sono state trattenute dall'emittente per soddisfare gli obblighi di ritenuta fiscale legati al vesting delle RSU e non corrispondono a una vendita sul mercato aperto.

Informe interno de Oscar Health: Adam McAnaney, el Chief Legal Officer de la compañía, dispuso de 1.845 acciones ordinarias Clase A el 02/09/2025 a un precio informado de $16,66 por acción. Tras la operación, posee de forma beneficiaria 181.093 acciones, incluidas las que se emitirán al consolidarse las unidades de acciones restringidas (RSU). La presentación indica que las 1.845 acciones fueron retenidas por el emisor para satisfacer obligaciones de retención fiscal relacionadas con el vesting de las RSU y no se vendieron en el mercado abierto.

Oscar Health 내부 보고: 회사의 최고법무책임자(Chief Legal Officer)인 Adam McAnaney는 2025년 9월 2일에 Class A 보통주 1,845주를 주당 $16.66의 신고가로 처분했습니다. 거래 후 그는 제약주식단위(RSU)의 베스팅 시 발행될 주식을 포함해 실질적으로 181,093주를 보유하고 있습니다. 서류에는 해당 1,845주가 공개 시장에서의 매도가 아니라 RSU 베스팅과 관련된 세금 원천징수 의무를 충족하기 위해 발행자가 주식을 원천징수한 것이라고 명시되어 있습니다.

Information interne d'Oscar Health : Adam McAnaney, directeur juridique de la société, a cédé 1 845 actions ordinaires de catégorie A le 02/09/2025 à un prix déclaré de 16,66 $ par action. Après la transaction, il détient de manière bénéficiaire 181 093 actions, y compris celles qui seront émises lors du vesting des restricted stock units (RSU). le dépôt indique que les 1 845 actions ont été retenues par l'émetteur pour satisfaire les obligations de retenue fiscale liées au vesting des RSU et ne résultent pas d'une vente sur le marché ouvert.

Insider-Meldung von Oscar Health: Adam McAnaney, Chief Legal Officer des Unternehmens, veräußerte am 02.09.2025 1.845 Aktien der Klasse A zu einem gemeldeten Preis von $16,66 je Aktie. Nach der Transaktion besitzt er wirtschaftlich 181.093 Aktien, einschließlich der Aktien, die bei Vesting von Restricted Stock Units (RSUs) ausgegeben werden. Die Meldung gibt an, dass die 1.845 Aktien vom Emittenten einbehalten wurden, um Steuerabzugsverpflichtungen im Zusammenhang mit dem Vesting der RSUs zu erfüllen, und nicht durch einen Verkauf am offenen Markt erzielt wurden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McAnaney Adam

(Last) (First) (Middle)
75 VARICK STREET, 5TH FLOOR

(Street)
NEW YORK NY 10013

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/02/2025 F 1,845(1) D $16.66 181,093(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs").
2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
Remarks:
/s/ Melissa Curtin, Attorney-in-fact 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Oscar Health (OSCR) insider Adam McAnaney report?

He reported a disposition of 1,845 shares of Class A common stock, withheld to satisfy tax obligations on vested RSUs, leaving 181,093 shares beneficially owned.

Was the insider sale an open-market sale or tax withholding?

The filing states the shares were withheld by the issuer to satisfy tax withholding obligations incident to RSU vesting, not an open-market sale.

What price per share was reported for the transaction?

The reported price for the withheld shares was $16.66 per share.

What is Adam McAnaneys role at Oscar Health?

He is identified as the companys Chief Legal Officer and the Form 4 was filed by one reporting person.

Does this Form 4 indicate any change in control or large insider selling?

No. The disposition is a tax withholding related to RSU vesting and represents a small portion of the reported post-transaction holdings.
Oscar Health Inc

NYSE:OSCR

OSCR Rankings

OSCR Latest News

OSCR Latest SEC Filings

OSCR Stock Data

4.75B
212.61M
4.05%
76.86%
23.24%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
NEW YORK